From multiple studies, it is very clear that higher staining for PDL-1 on tumors and immune cells (combined expression, resulting in the CPS (combined positive score)) is correlated with increased Response Rate, PFS and clinical benefit of anti-PD1 drugs.  Pembrolizumab is approved for gastric ...